C12N 9/48
Acting on peptide bonds
Official title: acting on peptide bonds (3.4)
C12N9/48 (Acting on peptide bonds) appears on 6,841 US grants and 8,502 published applications in this corpus.
Search patents in C12N- Granted patents
- 6,841
- Published applications
- 8,502
- Assignees
- 3,037
- Inventors
- 15,790
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 16 | 0 |
| 1978 | 17 | 0 |
| 1979 | 11 | 0 |
| 1980 | 13 | 0 |
| 1981 | 24 | 0 |
| 1982 | 25 | 0 |
| 1983 | 19 | 0 |
| 1984 | 25 | 0 |
| 1985 | 31 | 0 |
| 1986 | 23 | 0 |
| 1987 | 29 | 0 |
| 1988 | 45 | 0 |
| 1989 | 35 | 0 |
| 1990 | 66 | 0 |
| 1991 | 67 | 0 |
| 1992 | 94 | 0 |
| 1993 | 108 | 0 |
| 1994 | 102 | 0 |
| 1995 | 98 | 0 |
| 1996 | 114 | 0 |
| 1997 | 169 | 0 |
| 1998 | 259 | 0 |
| 1999 | 254 | 0 |
| 2000 | 214 | 0 |
| 2001 | 236 | 34 |
| 2002 | 203 | 354 |
| 2003 | 200 | 586 |
| 2004 | 161 | 391 |
| 2005 | 137 | 326 |
| 2006 | 192 | 294 |
| 2007 | 229 | 202 |
| 2008 | 156 | 237 |
| 2009 | 126 | 296 |
| 2010 | 173 | 262 |
| 2011 | 178 | 264 |
| 2012 | 153 | 252 |
| 2013 | 154 | 248 |
| 2014 | 164 | 303 |
| 2015 | 179 | 323 |
| 2016 | 182 | 335 |
| 2017 | 206 | 331 |
| 2018 | 210 | 337 |
| 2019 | 236 | 401 |
| 2020 | 255 | 397 |
| 2021 | 269 | 396 |
| 2022 | 226 | 398 |
| 2023 | 198 | 417 |
| 2024 | 192 | 458 |
| 2025 | 210 | 367 |
| 2026 | 144 | 293 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Protease composition6 Oct 2026US 12,751,997 B2Anatara Lifesciences Limited
- Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement6 Oct 2026US 12,753,411 B2The Brigham and Women S Hospital, Inc.
- Cleaning compositions comprising dispersins VI29 Sep 2026US 12,747,416 B2Henkel AG & Co. KGaA
- Collagenase agent and use thereof29 Sep 2026US 12,747,435 B2Amano Enzyme Inc.
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Method for producing plant-based cheese8 Oct 2026US 2026/0305639 A1Amano Enzyme Inc.
- Method for producing soybean composition having improved flavor8 Oct 2026US 2026/0305651 A1Godo Shusei Co., Ltd.
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Prophylactic/therapeutic agent for pregnancy-induced hypertension8 Oct 2026US 2026/0308559 A1Medical Corporation Saneikai
Most cited
By later US patents
- CRISPR-Cas systems and methods for altering expression of gene products1,186US 8,697,359 B1Massachusetts Institute of Technology · 2014
- Plasminogen activator derivatives616US 4,640,835 ANippon Chemiphar Co., Ltd. · 1987
- Isolation of exogenous recombinant proteins from the milk of transgenic mammals500US 4,873,316 ABiogen, Inc. · 1989
- CRISPR-Cas systems and methods for altering expression of gene products483US 8,945,839 B2Massachusetts Institute of Technology · 2015
- CRISPR-Cas systems and methods for altering expression of gene products470US 8,771,945 B1Massachusetts Institute of Technology · 2014